20/05/2021

Advanced Therapies bring tranformational value to European patients

30/09/2020

EuropaBio Patient engagement with the European Medicines Agency

EuropaBio Patient engagement with the European Medicines Agency
19/06/2020

ACCELERATE FAIR Initiative Letter of Support

We do appreciate the efforts led by the FAIR Initiative and hope to continue to partner with ACCELERATE to speed up the delivery of innovative therapies to children and adolescents.
20/05/2020

The impact of COVID-19 on patients with chronic or life-threatening conditions

Read our latest blog on the impact of the pandemic on patients with chronic diseases and rare conditions around the globe.
30/04/2020

EuropaBio reply letter to European Patients’ Forum’s call on COVID-19

EuropaBio reply letter to EPF's call on COVID-19.
10/10/2019

EuropaBio Patients BioForum – Key Messages

Read the key recommendations of the EuropaBio Patients BioForum to the new EU institutions.
29/11/2017

European Commission launches: “What I need to know about Biosimilar Medicines – Information for patients”, in 23 EU languages

This document outlines the proposals put forth by EuropaBio members with regard to the changes to the Summary of Product Characteristics (SmPC) of biosimilars, which we consider would result in an enhanced level of transparency in the label.
23/01/2017

European Commission Initiative Improves Information for Patients on Biosimilar Medicines

European Commission Initiative Improves Information for Patients on Biosimilar Medicines.
Become a member